Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Although Pacira is not a household name, its fight against the FDA was backed by a consortium of 11 of the biggest names in the pharmaceuticals industry — including Johnson & Johnson, Pfizer, GlaxoSmithKline...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Four years ago, when Pfizer bought Roger Newton’s company Esperion Therapeutics for $1.3bn, the pharmacologist and co-discoverer of the cholesterol-lowering drug Lipitor was deciding how to use his share...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Novartis and Pfizer, both of which have been cited as potential buyers of the company, fell 0.7 per cent to $54.33 and 0.8 per cent to $21.91 respectively....
...Mylan Laboratories rose 5.5 per cent to $20.44 as the Food and Drug Administration gave it the go-ahead to market a generic version of Norvasc, Pfizer’s blood pressure medication....
...In Risk Society: Towards a New Modernity, Ulrich Beck, a German sociologist, and pre-eminent thinker in this field, argues that these attitudes are historically unparalleled....
...Pfizer, the drugmaker, rose 2.6 per cent to $29.45 while Wyeth added 3.7 per cent at $40.80....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition